Today’s Research Reports on Trending Tickers: Gilead Sciences and bluebird bio

NEW YORK, NY / ACCESSWIRE / June 5, 2018 / Wall Street closed up Monday on the back of strong performances by the consumer discretionary and technology sectors. Investors appear to be focusing on positive economic data, instead of recent geopolitical concerns. The Dow Jones Industrial Average increased 0.72 percent to close at 24,813.69, while the S&P 500 Index climbed 0.45 percent to close at 2,746.87. The Nasdaq Composite Index was up 0.69 percent to close at 7,606.46.

“Latest economic reports indicate that consumers finally have confidence and extra income to spend on big-ticket items. Really low levels of unemployment and underemployment bode well for the retail sector and the market in general,” said Diane Jaffee, senior portfolio manager at TCW Group.

“It is always a plus to have a tech behemoth like Apple touching all-time highs, since Apple makes up such a huge part of all three major indices,” said Ken Berman, strategist at Gorilla Trades.

RDI Initiates Coverage on:

Gilead Sciences, Inc.
https://rdinvesting.com/news/?ticker=GILD

bluebird bio, Inc.
https://rdinvesting.com/news/?ticker=BLUE

Gilead Sciences’ stock moved 2.8% higher Monday, to close the day at $70.21. The stock recorded a trading volume of 11,012,617 shares, which was above its three months average volume of 7,279,128 shares. In the last year, Gilead Sciences’ shares have traded in a range of 63.76 – 89.54. The share price has gained 10.12% from its 52 week low. The company’s shares are currently trading below their 200-day moving average. The stock’s 50-day moving average of $69.37 is below its 200-day moving average of $75.23. Shares of the company are trading at a Price to Earnings ratio of 26.71. Shares of Gilead Sciences have gained roughly 7.32 percent in the past month and are down 2 percent year-to-date.

Access RDI’s Gilead Sciences, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=GILD

On Monday, shares of bluebird bio recorded a trading volume of 2,232,930 shares, which was above the three months average volume of 754,151 shares. The stock ended the day 4.88% higher at $191.30. The share price has fallen 19% from its 52-week high with a 52-week trading range of 85.65 – 236.17. The company’s shares are currently trading above their 200-day moving average. The stock’s 50-day moving average of $177.29 is below its 200-day moving average of $184.92. Shares of bluebird bio have gained roughly 9.88 percent in the past month and are up 7.41 percent year-to-date.

Access RDI’s bluebird bio, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=BLUE

Our Actionable Research on Gilead Sciences, Inc. (NASDAQ :GILD) and bluebird bio, Inc. (NASDAQ :BLUE) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com

ReleaseID: 501781